Categories

Popular tags

View all
All Formulations
Moxifloxacin 5mg/mL
Add this to my Favorites list

Moxifloxacin Injectable 0.5%

(Moxifloxacin 5mg/mL)
  • Unit Size: 1 ML
  • Package Size: 20 per Box
  • Package Price: $350.00

5mg/mL (4mg/0.8mL)
Shipped in boxes of 20 vials

Free ground shipping. Single-use vials.

Click here for the full package insert.
SKU: 300000011364262
Manufacturer part number: DL003
*

Please select a clinical difference for this product.

*
Box(es) of 20
Specifications
  • Unit Type: Vial
  • Classification: Injectable
  • Sub-Classification: Solution
  • Storage: Room Temperature
  • NDC Number: 71384-0511-01
  • Preservative Free
Related Formulations
Dex-Moxi (Dexamethasone and Moxifloxacin)

Dex-Moxi® Injectable

(Dexamethasone 1mg and moxifloxacin 5mg/mL)
  • Unit Size: 1 ML/Unit
  • Package Size: 20
  • Package Price: $580.00
Epi-Lido Injectable

Epi-Lido Injectable

(Lidocaine 0.75% and epinephrine in BSS 0.025%)
  • Unit Size: 1 ML/Unit
  • Package Size: 20
  • Package Price: $350.00
MKO Melt Sublingual

MKO Melt®

(Midazolam 3mg, ketamine 25mg and ondansetron 2mg)
  • Unit Size: 1 EA/Unit
  • Package Size: 21
  • Package Price: $367.50
Customers who bought this item also bought
Phenyl-Lido Injectable

Phenyl-Lido Injectable

(Phenylephrine 1.5% and lidocaine 1%)
  • Unit Size: 1 ML/Unit
  • Package Size: 20
  • Package Price: $350.00
Epi-Lido Injectable

Epi-Lido Injectable

(Lidocaine 0.75% and epinephrine in BSS 0.025%)
  • Unit Size: 1 ML/Unit
  • Package Size: 20
  • Package Price: $350.00
MKO Melt Sublingual

MKO Melt®

(Midazolam 3mg, ketamine 25mg and ondansetron 2mg)
  • Unit Size: 1 EA/Unit
  • Package Size: 21
  • Package Price: $367.50
Mydriatic 4 Multi-Dose Bottle

Mydriatic 4 Multi-Dose

(Tropicamide 1%, proparacaine 0.5%, phenylephrine 2.5% and ketorolac 0.5%)
  • Unit Size: 5 ML/Unit
  • Package Size: 2
  • Package Price: $140.00
*For professional use only. ImprimisRx® Pharmacy specializes in customizing medications to meet unique patient and practitioner needs. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.